See the raw experimental evidence behind an author's publications and reproducibility signals.
Press Enter ↵ to solve
Fuel Your Discoveries
"Biology is a science of three dimensions. The first is the study of each species across all levels of biological organization, molecule to cell to organism to population to ecosystem. The second dimension is the diversity of all species in the biosphere. The third dimension is the history of each species in turn, comprising both its genetic evolution and the environmental change that drove the evolution."
Strong recurring niche in gut microbiota/IBD and diet/FMT consensus & mechanistic reviews, with demonstrable citation footprint (OpenAlex h-index/citations provided by user data).
Likely translational orientation: many works listed are real-world effectiveness/safety studies and IBD-targeted mechanistic themes (IBD, microbiota, barrier, inflammation).
Main scientific risk: without paper-level methods/QC for each listed study, I can’t validate effect sizes, causality, or reproducibility—real-world/observational designs can be confounded.
Today’s date: April 09, 2026. This review is limited to the specific metadata and paper titles/identifiers you provided (OpenAlex metrics + the listed works), so any deeper evaluation of methodology (e.g., randomization, blinding, assay validity) is not possible from your input alone.
Provided OpenAlex match for Franco Scaldaferri: cited_by_count = 14534, h_index = 56, works_count = 541. These are aggregate bibliometrics; they do not guarantee rigor of any single paper and can be affected by review papers, coauthorship networks, and field size.
2) Publication velocity & open-access signal (from provided counts_by_year)
The user-provided OpenAlex counts_by_year shows both works_count and oa_works_count by year. This is useful context for trend analysis, but not proof of quality.
Skeptical note
Even if OA counts rise, bibliometrics can reflect survey/consensus/review publication propensity and field growth, not necessarily methodological superiority.
3) Scientific focus areas inferred from provided metadata
From the provided OpenAlex topics, the highest score categories include: Medicine, Inflammatory bowel disease, Gastroenterology, Internal medicine, Disease. This aligns with the user-provided list of IBD/microbiota/diet/FMT papers.
4) Concrete paper-level evidence for scientific themes (from the provided OpenAlex “top works” with DOIs)
Below are specific cited works where the DOI/full bibliographic metadata you provided allows inline citation, enabling evidence-grounded critique of the scientific direction (rather than mere topic labels).
4.1 Method/clinical-translation orientation: consensus on FMT and stool banking
European consensus conference on faecal microbiota transplantation (clinical practice)
This work reflects an attempt to standardize clinical use of FMT where evidence exists (notably for recurrent Clostridioides difficile), which is scientifically relevant because harmonized protocols reduce variability and improve interpretability across studies.
Key extract:
International consensus conference on stool banking for FMT
Stool banking consensus is relevant to biological rigor (donor screening, processing, storage, traceability), which directly impacts microbiome composition and clinical outcomes.
Key extract:
4.2 Mechanistic gut microbial ecology & inflammation links
Commensal Clostridia as gut homeostasis maintainers
This review suggests roles for commensal clostridia in maintaining intestinal homeostasis—biologically plausible, but still relies on mixed evidence types (animal models, in vitro work, observational human correlations), so causality should be treated cautiously.
Food components and dietary habits for gut microbiota composition
This review positions diet as a major driver of microbiota ecosystem state. Reviews are helpful for organizing hypotheses but typically cannot replace causal evidence.
Key extract:
4.4 Barrier/inflammation conceptual integration
Gut microbiota, intestinal permeability, and systemic inflammation
This narrative review links barrier function to systemic inflammation, which is biologically plausible, but—again—narrative reviews aggregate heterogeneous measures (permeability assays, inflammatory markers) and can overemphasize coherence.
VEGF-A links angiogenesis and inflammation in IBD pathogenesis
This is a primary research article (as provided). Mechanistically, VEGF-A is a coherent molecular bridge between angiogenesis and inflammation, but the strength depends on experimental design and controls—those details are not present in your prompt.
Key extract:
5) Critical synthesis: what the provided body of work suggests (and what remains unverified)
What seems likely strong
Topic integration across microbiota ecology, barrier function, and clinical translation: this is consistent with the cited consensus and mechanistic/review works you provided (FMT clinical/stool banking consensus; microbiota homeostasis review; permeability–inflammation narrative review; diet–microbiota review; VEGF-A mechanistic framing).
Translational awareness that “how you prepare microbiota” matters (processing/banking standardization), which is a key scientific confound in microbiome therapeutics.
Main scientific limitations / blind spots (given the information provided)
No paper-level methods are supplied for the majority of listed works (e.g., randomization, blinding, sample size, confound handling, effect sizes). Without that, I cannot adjudicate rigor across the author’s 25-papercount list you provided.
Observational/real-world study risk: many listed abstracts appear to be “real-world effectiveness and safety” or registry/IPTW analyses. These can be valuable but remain vulnerable to confounding, selection bias, and residual bias. (I can’t evaluate which confounders were included because the prompt contains only titles/IDs.)
Review/narrative synthesis risk: narrative reviews (e.g., permeability–inflammation) can be compelling but are not designed to quantify effect sizes across studies and can reflect selection of literature emphasis. The cited extract you provided is therefore evidence-strength weak-to-moderate for causal claims.
6) Paper list quality signals (from your provided titles only)
Your provided “papers” list contains many IBD/microbiota/diet/muscle-sarcopenia themes and several studies marked as real-world or model-based. However, because titles alone don’t show study design quality, any scoring is necessarily coarse.
Important limitation: This chart is based solely on the titles you provided; it does not measure rigor or effect sizes.
7) Final critical scoring (how strong is the author scientifically, based on provided evidence only?)
Scientific quality (score rationale): Bibliometrics suggest high impact and sustained productivity; the provided DOI-backed works show engagement with clinical standardization (FMT consensus) and biologically coherent mechanistic areas (barrier/inflammation, microbial ecology, VEGF-A/angiogenesis-inflammation framing). However, your prompt does not include methods/results for most listed items, so I cannot verify rigor across the full publication set.
Scientific rigor risk: narrative/review works are not direct causal evidence; real-world and single-center analyses can be confounded; model-based claims depend on translational validity.
Action buttons
This will independently pull and analyze the underlying paper content (not just titles/metadata) to evaluate methods, confounding control, and reproducibility where possible.
Feedback:
Updated: April 09, 2026
BGPT Author Review
Scientific Quality
70%
Strength signals: very high aggregate bibliometric impact in a coherent niche (IBD/gut microbiota/diet/FMT and inflammation/immune mechanisms), plus at least some DOI-identified works spanning clinical standardization (FMT consensus) and mechanistic framing (VEGF-A/angiogenesis-inflammation; commensal Clostridia; diet–microbiota; permeability–inflammation narrative). Main weaknesses: the prompt provides no paper-level methodological details for most listed works, so I cannot verify effect size accuracy, confounding handling, assay validity, blinding/randomization, or reproducibility; narrative/review work limits causal strength; real-world/observational studies carry confounding risk by default.
Communication Quality
60%
Based on the provided material only, communication quality cannot be fully judged (no writing samples, abstracts, or full text). The presence of consensus statements suggests capability to communicate across stakeholders, but the prompt lacks enough detail to score confidently.
Author Novelty
50%
The author appears strongly engaged in consensus and synthesis work; that is valuable but typically incremental rather than paradigm-shifting. Without the underlying full-text innovations, I cannot confirm novel experimental breakthroughs from the titles/metadata alone.
Scientific Rigor
60%
Rigor is plausibly supported by involvement in clinical standardization (FMT stool banking consensus) and mechanistic research themes, but the prompt does not provide methods/results for most studies, so rigor across the full set is unverified. Narrative reviews and real-world observational designs reduce certainty about causal mechanisms unless supported by robust primary experiments.
I will automatically parse the author’s DOI-available works, extract study design and key outcome variables, then generate a cross-study evidence matrix for IBD/microbiota/diet/FMT using only the paper text you provide.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The simplistic idea that “higher microbiota diversity always equals better IBD outcomes” is likely too coarse; donor dependence and functional composition are emphasized by the provided FMT/diet themes, implying context-specific ecology.
Assuming intestinal permeability is a direct upstream cause of systemic inflammation is likely overconfident; the provided narrative permeability–inflammation framing indicates association-level synthesis that may not establish directionality.
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)